Urgent QuestionGorsky, who has been leading the 150,000-person health-care conglomerate remotely by Zoom, joked that he’s asked “almost every 15 minutes" when a vaccine will be available.“We would expect by late this year, early next year, we should be in a position to begin reviews with regulatory authorities to see if our vaccine is in fact safe, effective, and something that could be considered for an emergency use authorization," Gorsky said, reaffirming J&J’s previously-stated timeline.An emergency use authorization would likely allow a limited supply of shots to go to specific at-risk populations, like health-care and essential workers.